Company intelligence / Profile preview
Harbin Medisan Pharmaceutical
Harbin, Heilongjiang, Chinamedisan.com.cn ↗
- Ownership
- Private
- Employees
- ~2522
- Development stage
- Other
01
Overview
Harbin Medisan Pharmaceutical is a publicly listed Chinese pharmaceutical company with a broad commercial portfolio of generic and specialty small molecule drugs across multiple therapeutic areas. The company has several early-stage clinical programs targeting neurological and autoimmune indications.
- Therapeutic areas
- NeurologyInfectious DiseasesGastroenterologyOncologyImmunologyRheumatologyCardiovascular
- Modalities
- Small moleculeChemical drugs
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Not specifically disclosed in public sources.
Beyond the preview
Go deeper on Harbin Medisan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Harbin Medisan Pharmaceutical.